ORIC Pharmaceuticals, Inc. (ORIC) Misses Q2 EPS by 3c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q2 EPS of ($0.47), $0.03 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Activist investors push Seer, Inc. to disclose go-private timeline
• Popular stocks with increasing option volume: SPCX MU SMCI INTC AMZN NFLX HTZ MSTR NBIS PLTR SNDK CRWV ORCL CSCO
• Active options: NVDA TSLA SPCX MU SMCI INTC AAPL IREN AMZN